tiprankstipranks
Advertisement
Advertisement

DE:IDP Stock Latest News

Biogen completes acquisition of RayThera
The FlyBiogen completes acquisition of RayThera
7d ago
BIIB
Biogen price target raised to $241 from $221 at Mizuho
PremiumThe Fly
Biogen price target raised to $241 from $221 at Mizuho
9d ago
BIIB
Biogen price target raised to $215 from $200 at Citi
PremiumThe Fly
Biogen price target raised to $215 from $200 at Citi
10d ago
BIIB
Biogen price target raised to $231 from $222 at Morgan Stanley
PremiumThe Fly
Biogen price target raised to $231 from $222 at Morgan Stanley
14d ago
BIIB
Biogen price target raised to $251 from $237 at H.C. Wainwright
PremiumThe Fly
Biogen price target raised to $251 from $237 at H.C. Wainwright
14d ago
BIIB
Biogen price target lowered to $240 from $242 at RBC Capital
PremiumThe FlyBiogen price target lowered to $240 from $242 at RBC Capital
14d ago
BIIB
Biogen price target raised to $240 from $225 at UBS
Premium
The Fly
Biogen price target raised to $240 from $225 at UBS
14d ago
BIIB
Biogen price target raised to $215 from $201 at Wedbush
Premium
The Fly
Biogen price target raised to $215 from $201 at Wedbush
14d ago
BIIB
Biogen price target raised to $219 from $215 at BofA
PremiumThe Fly
Biogen price target raised to $219 from $215 at BofA
14d ago
BIIB
Biogen price target raised to $225 from $215 at TD Cowen
PremiumThe Fly
Biogen price target raised to $225 from $215 at TD Cowen
14d ago
BIIB
Biogen price target raised to $248 from $245 at Canaccord
PremiumThe Fly
Biogen price target raised to $248 from $245 at Canaccord
14d ago
BIIB
Biogen Earnings Call: Growth Engines Offset Near-Term Drag
PremiumCompany Announcements
Biogen Earnings Call: Growth Engines Offset Near-Term Drag
15d ago
BIIB
Biogen: Buy Rating Reiterated on Strong Q2 Beat and Upgraded 2026 Outlook; Price Target Maintained at $256
PremiumRatingsBiogen: Buy Rating Reiterated on Strong Q2 Beat and Upgraded 2026 Outlook; Price Target Maintained at $256
15d ago
BIIB
Morning Movers: Generac, Amphenol climb following earnings
Premium
The Fly
Morning Movers: Generac, Amphenol climb following earnings
15d ago
F
V
Biogen lowers FY26 EPS view to $12.00-$13.00 from $14.25-$15.25
Premium
The Fly
Biogen lowers FY26 EPS view to $12.00-$13.00 from $14.25-$15.25
15d ago
BIIB
Biogen reports Q2 EPS $3.60, consensus $2.05
PremiumThe Fly
Biogen reports Q2 EPS $3.60, consensus $2.05
15d ago
BIIB
Biogen price target raised to $200 from $185 at Barclays
PremiumThe Fly
Biogen price target raised to $200 from $185 at Barclays
15d ago
BIIB
BIIB Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
BIIB Upcoming Earnings Report: What to Expect?
17d ago
BIIB
Biogen: Balanced Risk-Reward Keeps Rating at Hold Amid MS Pressure and Uncertain New Asset Contributions
PremiumRatings
Biogen: Balanced Risk-Reward Keeps Rating at Hold Amid MS Pressure and Uncertain New Asset Contributions
23d ago
BIIB
Biogen price target raised to $280 from $260 at Guggenheim
PremiumThe FlyBiogen price target raised to $280 from $260 at Guggenheim
23d ago
BIIB
Biogen price target lowered to $215 from $217 at BofA
Premium
The Fly
Biogen price target lowered to $215 from $217 at BofA
23d ago
BIIB
Biogen appoints Michael Parini as chief legal officer
Premium
The Fly
Biogen appoints Michael Parini as chief legal officer
29d ago
BIIB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >